NEVVI Medicare utilization intelligence

← back

CANFIELD, CRAIGM.D. NPI 1053403774 Clinician

Urology · SAN LUIS OBISPO, CA

Specialty Urology — from billed Medicare claims
In practice about 33 years since medical school (class of 1993, self-reported to CMS)
Location SAN LUIS OBISPO, CA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 42 codes billed · 49,310 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
UROLOGY ASSOCIATES OF THE CENTRAL COAST
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-11

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3145 Injection, testosterone undecanoate, 1 mg
J0897 Injection, denosumab, 1 mg
J9030 Bcg live intravesical instillation, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0585 Injection, onabotulinumtoxina, 1 unit
81003 Automated urinalysis test
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
51798 Ultrasound measurement of bladder capacity after voiding
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J3490 Unclassified drugs
52000 Diagnostic exam of bladder and urethra using an endoscope
96372 Injection of drug or substance under skin or into muscle
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
64566 Insertion of lower leg neurostimulator electrode
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99459 Pelvic exam
76942 Ultrasonic guidance for needle placement
A4648 Tissue marker, implantable, any type, each
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
51720 Instillation of anti-cancer drug into bladder
J0696 Injection, ceftriaxone sodium, per 250 mg
55700 Biopsy of prostate gland
11980 Placement of hormone pellet under skin
51741 Electronic assessment of bladder emptying
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
51797 Insertion of device into abdomen with pressure and urine flow rate study
50590 Shock wave crushing of kidney stones
51703 Complicated insertion of bladder tube
52235 Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm
55876 Placement of device in prostate for radiation therapy
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies
52287 Exam with injections of chemical for destruction of bladder using an endoscope
52601 Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope
51729 Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies
52332 Insertion of stent in ureter using an endoscope
74420 Imaging of urinary tract following injection of a contrast agent
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
51701 Insertion of temporary bladder tube
52240 Destruction and/or removal of large growth of bladder using an endoscope

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.